Valeant Pharmaceuticals Comments On Management Change

03/02/2016

Valeant Pharmaceuticals International, Inc. today issued the following comments in response to inquiries from investors regarding Deb Jorn's departure from Valeant.

Register

We're glad to see you're enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free